Sign In
Buy OPY
$106.64
-4.06 (-3.67%)
At Close: Jul 31, 2026
Oppenheimer Appoints Chris DeFalco And John Hyland As Co-Heads Of Equity Capital Markets
06:00am, Tuesday, 24'th Mar 2026
Peter Bennett to Lead Corporate Executive Services Team NEW YORK, March 24, 2026 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager, and subsidiary of Opp
Oppenheimer Names Eric Nortman Head of Debt Private Placements
06:00am, Tuesday, 17'th Mar 2026
Private credit executive to lead newly launched debt private placements group, expanding financing solutions for investment banking clients. NEW YORK, March 17, 2026 /PRNewswire/ -- Oppenheimer & Co
Guardian Pharmacy Services, Inc. to Participate in Upcoming Oppenheimer Healthcare MedTech & Services Conference
04:30pm, Tuesday, 10'th Mar 2026
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Fred
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
08:30am, Tuesday, 10'th Mar 2026
HINGHAM, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it will be pa
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
07:00am, Thursday, 05'th Mar 2026
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA
Jade Biosciences, Inc. (JBIO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Prepared Remarks Transcript
LPL Financial (NASDAQ:LPLA) and Oppenheimer (NYSE:OPY) Financial Review
01:42am, Friday, 27'th Feb 2026
LPL Financial (NASDAQ: LPLA - Get Free Report) and Oppenheimer (NYSE: OPY - Get Free Report) are both finance companies, but which is the better business? We will contrast the two companies based on t
Oppenheimer Appoints Vien Le As Managing Director
06:00am, Wednesday, 25'th Feb 2026
Seasoned municipal finance leader joins the firm's Public Finance Investment Banking Group and will be based in Los Angeles NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer
Actuate Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
08:45am, Tuesday, 24'th Feb 2026
CHICAGO and FORT WORTH, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on d
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Truist Securit
Corvus Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
04:01pm, Monday, 23'rd Feb 2026
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership t
Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
08:30am, Monday, 23'rd Feb 2026
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference
08:00am, Monday, 23'rd Feb 2026
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-bas
Oppenheimer Channel Checks Bode Well for These 2 Cybersecurity Stocks
08:05am, Sunday, 22'nd Feb 2026
CrowdStrike continues to be the leader in the next-generation endpoint security space. SentinelOne appears to have had the biggest positive change in sentiment among channel partners.
Oppenheimer (NYSE:OPY) Share Price Passes Above 200-Day Moving Average – Should You Sell?
04:33am, Saturday, 21'st Feb 2026
Oppenheimer Holdings, Inc. (NYSE: OPY - Get Free Report)'s stock price passed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $73.84 and traded as
